Market Closed -
NSE India S.E.
07:43:48 2024-06-06 am EDT
|
5-day change
|
1st Jan Change
|
1,162
INR
|
-1.24%
|
|
-7.02%
|
+4.37%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
124,059
|
175,914
|
241,495
|
270,385
|
205,589
|
298,445
|
-
|
-
|
Enterprise Value (EV)
1 |
126,717
|
179,826
|
239,835
|
275,070
|
201,870
|
325,349
|
307,275
|
300,774
|
P/E ratio
|
28
x
|
29.2
x
|
21.1
x
|
30.6
x
|
43.6
x
|
57.4
x
|
33.4
x
|
25.1
x
|
Yield
|
0.31%
|
0.36%
|
0.42%
|
0.75%
|
0.49%
|
0.41%
|
0.46%
|
0.54%
|
Capitalization / Revenue
|
3.29
x
|
3.78
x
|
4.46
x
|
4.64
x
|
3.29
x
|
4.07
x
|
3.27
x
|
2.87
x
|
EV / Revenue
|
3.36
x
|
3.87
x
|
4.43
x
|
4.72
x
|
3.23
x
|
4.22
x
|
3.37
x
|
2.9
x
|
EV / EBITDA
|
18.4
x
|
19.8
x
|
15.5
x
|
21
x
|
21.8
x
|
24.6
x
|
18.4
x
|
14.4
x
|
EV / FCF
|
40.6
x
|
69.7
x
|
32.9
x
|
72.9
x
|
64.8
x
|
60.9
x
|
40
x
|
34.9
x
|
FCF Yield
|
2.46%
|
1.43%
|
3.04%
|
1.37%
|
1.54%
|
1.64%
|
2.5%
|
2.86%
|
Price to Book
|
3.95
x
|
4.85
x
|
5.14
x
|
4.92
x
|
2.58
x
|
4.96
x
|
4.12
x
|
3.63
x
|
Nbr of stocks (in thousands)
|
252,704
|
252,704
|
253,704
|
253,704
|
253,704
|
253,704
|
-
|
-
|
Reference price
2 |
490.9
|
696.1
|
951.9
|
1,066
|
810.4
|
1,176
|
1,176
|
1,176
|
Announcement Date
|
5/29/19
|
6/16/20
|
5/28/21
|
5/24/22
|
5/29/23
|
5/29/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
37,732
|
46,487
|
54,200
|
58,298
|
62,443
|
77,050
|
91,234
|
103,817
|
EBITDA
1 |
6,901
|
9,067
|
15,444
|
13,073
|
9,268
|
13,212
|
16,730
|
20,921
|
EBIT
1 |
5,076
|
6,962
|
13,352
|
10,748
|
6,652
|
9,639
|
12,625
|
16,372
|
Operating Margin
|
13.45%
|
14.98%
|
24.63%
|
18.44%
|
10.65%
|
12.51%
|
13.84%
|
15.77%
|
Earnings before Tax (EBT)
1 |
5,465
|
7,367
|
13,813
|
11,357
|
7,453
|
8,427
|
12,787
|
17,254
|
Net income
1 |
4,422
|
6,036
|
11,400
|
8,841
|
4,713
|
5,474
|
8,844
|
11,797
|
Net margin
|
11.72%
|
12.98%
|
21.03%
|
15.16%
|
7.55%
|
7.1%
|
9.69%
|
11.36%
|
EPS
2 |
17.50
|
23.86
|
45.06
|
34.85
|
18.58
|
21.57
|
35.24
|
46.87
|
Free Cash Flow
1 |
3,120
|
2,580
|
7,286
|
3,771
|
3,113
|
5,340
|
7,688
|
8,614
|
FCF margin
|
8.27%
|
5.55%
|
13.44%
|
6.47%
|
4.99%
|
6.93%
|
8.43%
|
8.3%
|
FCF Conversion (EBITDA)
|
45.21%
|
28.45%
|
47.18%
|
28.85%
|
33.59%
|
40.42%
|
45.95%
|
41.17%
|
FCF Conversion (Net income)
|
70.55%
|
42.74%
|
63.91%
|
42.65%
|
66.06%
|
97.57%
|
86.93%
|
73.02%
|
Dividend per Share
2 |
1.500
|
2.500
|
4.000
|
8.000
|
4.000
|
4.826
|
5.398
|
6.323
|
Announcement Date
|
5/29/19
|
6/16/20
|
5/28/21
|
5/24/22
|
5/29/23
|
5/29/24
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
14,098
|
11,147
|
15,658
|
15,444
|
14,305
|
12,891
|
15,857
|
16,010
|
15,460
|
15,116
|
15,876
|
17,241
|
20,834
|
20,430
|
EBITDA
1 |
3,669
|
2,289
|
4,165
|
3,656
|
3,078
|
2,193
|
2,692
|
2,606
|
2,159
|
1,810
|
3,076
|
3,381
|
3,433
|
3,189
|
EBIT
1 |
3,134
|
1,764
|
3,607
|
3,086
|
2,491
|
1,584
|
2,075
|
1,969
|
1,493
|
1,115
|
2,384
|
2,791
|
2,376
|
1,904
|
Operating Margin
|
22.23%
|
15.83%
|
23.03%
|
19.98%
|
17.41%
|
12.29%
|
13.09%
|
12.3%
|
9.66%
|
7.38%
|
15.01%
|
16.19%
|
11.41%
|
9.32%
|
Earnings before Tax (EBT)
1 |
3,243
|
1,921
|
3,774
|
3,256
|
2,607
|
1,696
|
2,227
|
2,238
|
1,693
|
1,294
|
2,518
|
2,699
|
2,369
|
1,844
|
Net income
1 |
2,655
|
1,613
|
3,067
|
2,502
|
1,970
|
1,302
|
1,431
|
1,439
|
1,078
|
765.2
|
1,628
|
1,911
|
1,667
|
1,294
|
Net margin
|
18.83%
|
14.47%
|
19.59%
|
16.2%
|
13.77%
|
10.1%
|
9.02%
|
8.99%
|
6.98%
|
5.06%
|
10.26%
|
11.09%
|
8%
|
6.33%
|
EPS
2 |
10.54
|
6.355
|
12.09
|
9.865
|
7.760
|
5.130
|
5.640
|
5.670
|
4.250
|
3.020
|
6.420
|
7.100
|
5.675
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/4/21
|
5/28/21
|
8/5/21
|
11/13/21
|
2/14/22
|
5/24/22
|
8/10/22
|
11/11/22
|
2/14/23
|
5/29/23
|
8/10/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,658
|
3,913
|
-
|
4,685
|
-
|
11,415
|
8,830
|
2,329
|
Net Cash position
1 |
-
|
-
|
1,660
|
-
|
3,720
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.3852
x
|
0.4315
x
|
-
|
0.3584
x
|
-
|
0.864
x
|
0.5278
x
|
0.1113
x
|
Free Cash Flow
1 |
3,120
|
2,580
|
7,286
|
3,771
|
3,113
|
5,341
|
7,688
|
8,614
|
ROE (net income / shareholders' equity)
|
15.2%
|
17.9%
|
27.4%
|
17.3%
|
8.34%
|
8.99%
|
12.4%
|
14.7%
|
ROA (Net income/ Total Assets)
|
10.2%
|
12.3%
|
20.1%
|
12.9%
|
5.8%
|
9.86%
|
12.6%
|
-
|
Assets
1 |
43,340
|
49,054
|
56,641
|
68,536
|
81,249
|
55,490
|
70,293
|
-
|
Book Value Per Share
2 |
124.0
|
144.0
|
185.0
|
216.0
|
314.0
|
250.0
|
286.0
|
324.0
|
Cash Flow per Share
2 |
19.50
|
22.30
|
43.00
|
33.70
|
31.80
|
37.20
|
48.10
|
46.40
|
Capex
1 |
1,805
|
3,063
|
3,616
|
4,790
|
4,945
|
4,106
|
4,236
|
4,090
|
Capex / Sales
|
4.78%
|
6.59%
|
6.67%
|
8.22%
|
7.92%
|
5.33%
|
4.64%
|
3.94%
|
Announcement Date
|
5/29/19
|
6/16/20
|
5/28/21
|
5/24/22
|
5/29/23
|
5/29/24
|
-
|
-
|
Last Close Price
1,176
INR Average target price
1,197
INR Spread / Average Target +1.75% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.37% | 3.58B | | +42.69% | 749B | | +38.85% | 605B | | -6.87% | 351B | | +18.74% | 328B | | +6.76% | 292B | | +18.96% | 248B | | -2.29% | 214B | | +11.28% | 216B | | +2.64% | 167B |
Other Pharmaceuticals
|